SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-214075
Filing Date
2020-08-10
Accepted
2020-08-10 07:10:52
Documents
3
Period of Report
2020-08-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d76779d8k.htm 8-K 17511
2 EX-99.1 d76779dex991.htm EX-99.1 45575
3 GRAPHIC g76779g91s42.jpg GRAPHIC 7651
  Complete submission text file 0001193125-20-214075.txt   74874
Mailing Address 2 WEST LIBERTY BLVD #100 MALVERN PA 19355
Business Address 2 WEST LIBERTY BLVD #100 MALVERN PA 19355 610-725-1500
Galera Therapeutics, Inc. (Filer) CIK: 0001563577 (see all company filings)

IRS No.: 461454898 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39114 | Film No.: 201087053
SIC: 2834 Pharmaceutical Preparations